<DOC>
	<DOCNO>NCT01846455</DOCNO>
	<brief_summary>The objective determine hepatitis C virus ( HCV ) infection mild severe hepatic impairment ( Child-Pugh Classes A , B , C ) alter PK buprenorphine , norbuprenorphine , naloxone .</brief_summary>
	<brief_title>Single Dose Pharmacokinetics Suboxone Study Hepatic Impaired Subjects</brief_title>
	<detailed_description>This multi-center , open-label study . After provide informed consent , subject undergo outpatient screen period 21 day . Screening procedure include assessment mental status repeat dose . Eligible subject undergo hospital intake procedure reside investigational site Day 5 . Subjects enrol 5-treatment group follow : ( 1 ) Group 1 : Subjects hepatic impairment classify Child-Pugh A ; ( 2 ) Group 2 : Subjects hepatic impairment classify Child-Pugh B ; ( 3 ) Group 3 : Subjects hepatic impairment classify Child-Pugh C ; ( 4 ) Group 4 : Subjects Hepatitis C Virus ( HCV ) infection without hepatic impairment ; ( 5 ) Group 5 : Subjects without hepatic disease impairment . Group 5 use control group</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Liver Failure</mesh_term>
	<mesh_term>Hepatic Encephalopathy</mesh_term>
	<mesh_term>Naloxone</mesh_term>
	<mesh_term>Buprenorphine , Naloxone Drug Combination</mesh_term>
	<mesh_term>Buprenorphine</mesh_term>
	<mesh_term>Diphenhydramine</mesh_term>
	<mesh_term>Promethazine</mesh_term>
	<criteria>Males female age 18 65 year , inclusive Females surgically sterile , 2 year postmenopausal negative plasma βhuman chorionic gonadotropin ( βhCG ) pregnancy test . Subjects childbearing potential must take reasonable precaution study avoid pregnancy agree remain abstinent practice doublebarrier form birth control time inform consent last study visit . A negative plasma pregnancy ( βhCG ) test Screening upon admission investigational site . Testing βhCG need time ensure negative pregnancy result Day 1 . Male subject agree use barrier contraception spermicide engage sexual activity female childbearing potential least 28 day study medication dose . Male subject agree refrain sperm donation entire duration study least 90 day study drug dose . Body mass index ( BMI ) ≥ 18 ≤ 33 kg^m2 . Subject agree condition study sign inform consent form Medical condition : ( ) pregnancy ; ( b ) breastfeed Psychiatric condition : ( ) current treatment opioid addiction substitution therapy ; ( b ) active history bipolar I , bipolar II , schizophrenia , schizophreniform ; schizoaffective ; mania , hypomania , severe posttraumatic stress disorder ; ( c ) presence suicidal behavior within year inform consent suicidal intent within 30 day inform consent document Columbia Suicide Severity Rating Scale Hypersensitivity opioids , define intractable vomiting , severe constipation , severe pruritus opioid treatment Subject know intolerance hypersensitivity buprenorphine naloxone excipients Suboxone tablet formulation In judgment investigator , condition would preclude safe , useful , consistent participation study Use investigational medication investigational medical device 30 day inform consent Hepatic encephalopathy great West Haven Grade 2 Donation &gt; 250 ml blood within previous 30 day Systolic BP ≤ 90 ≥ 160 mmHg and/or Diastolic BP &lt; 60 mmHg &gt; 100 mmHg History cholecystectomy History current acquire immunodeficiency syndrome ( AIDS ) human immunodeficiency virus ( HIV ) antibody Estimated creatinine clearance rate ( eC Cr ) use CockcroftGault formula &lt; 60 mL/min More 1 missed appointment Screening Currently mandate criminal justice system Child Family Services participate drug abuse treatment Participation drug alcohol dependence treatment 30 day inform consent Positive urine drug screen result amphetamine , methamphetamine , barbiturate , benzodiazepine , buprenorphine , cannabinoids , cocaine , methadone , opioids , oxycodone , phencyclidine , judgment investigator , indicative nonprescribed drug use ; and/or positive urine alcohol screen result , judgment investigator , indicative alcohol abuse alcoholism Consumption prohibit medication within 1 week inform consent , include buprenorphine Consumption grapefruit grapefruit juice least one week study dose end study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Hepatic</keyword>
	<keyword>Hepatitis C Virus</keyword>
	<keyword>Suboxone</keyword>
	<keyword>Buprenorphine</keyword>
	<keyword>Naloxone</keyword>
</DOC>